Dashboard
Manage Tickers

AKBA Akebia Therapeutics, Inc.

Nasdaq akebia.com


$ 1.81 $ 0.14 (8.38 %)    

Tuesday, 11-Nov-2025 15:59:58 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.49 $ 0.90 (0.15 %)
DIA $ 479.63 $ 5.34 (1.13 %)
SPY $ 683.37 $ 2.90 (0.43 %)
TLT $ 89.91 $ 0.01 (0.01 %)
GLD $ 380.58 $ -0.09 (-0.02 %)
$ 1.81
$ 1.68
$ 1.77 x 125
$ 1.84 x 60
$ 1.67 - $ 1.84
$ 1.52 - $ 4.08
5,189,379
na
480.31M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-13-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-14-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-28-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 03-10-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-26-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-12-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-06-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
11/10/2025 17:07:01

akebia-therapeutics-q3-sales-58766m-beat-58235m-estimate
Akebia Therapeutics Q3 Sales $58.766M Beat...
11/10/2025 12:04:01

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $58.766 million which beat the analyst consensus estimate of $58....

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

an-overview-of-akebia-therapeuticss-earnings
An Overview of Akebia Therapeutics's Earnings
11/07/2025 16:04:46

akebia-therapeutics-presents-data-at-asn-kidney-week-says-vadadustat-shows-statistically-significant-reduction-in-death-and-hospitalization-in-dialysis-patients
Akebia Therapeutics Presents Data At ASN K...
11/06/2025 23:35:11

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

top-3-health-care-stocks-which-could-rescue-your-portfolio-in-november
Top 3 Health Care Stocks Which Could Rescu...
11/04/2025 11:24:48

hc-wainwright--co-maintains-buy-on-akebia-therapeutics-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on Akebi...
10/30/2025 11:51:16

HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price...

fda-pushback-prompts-akebia-to-drop-broad-label-pursuit-for-kidney-disease-drug
FDA Pushback Prompts Akebia To Drop Broad ...
10/29/2025 18:13:46

Akebia shares decline after the company ends plans for its VALOR trial, citing FDA feedback and high costs tied to expanding Va...

btig-maintains-buy-on-akebia-therapeutics-lowers-price-target-to-5
BTIG Maintains Buy on Akebia Therapeutics,...
10/29/2025 17:49:36

BTIG analyst Julian Harrison maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price target from $10 to $5.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 17:06:03

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 12:06:08

mondelez-international-stride-varonis-systems-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Mondelez International, Stride, Varonis Sy...
10/29/2025 12:05:16

why-teradyne-shares-are-trading-higher-by-more-than-20-here-are-20-stocks-moving-premarket
Why Teradyne Shares Are Trading Higher By ...
10/29/2025 09:05:41

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/28/2025 21:13:44

akebia-therapeutics-says-fda-has-not-come-to-alignment-on-path-forward-for-design-of-valor-clinical-trial-for-use-of-vafseo-in-non-dialysis-patients
Akebia Therapeutics Says FDA Has Not Come ...
10/28/2025 20:34:48

akebia-therapeutics-and-innovative-renal-care-announce--vafseo-availability-in-irc-dialysis-clinics
Akebia Therapeutics And Innovative Renal C...
08/21/2025 12:10:09

akebia-therapeutics-q2-sales-62472m-beat-47637m-estimate
Akebia Therapeutics Q2 Sales $62.472M Beat...
08/07/2025 11:03:41

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $62.472 million which beat the analyst consensus estimate of $47....

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

earnings-preview-for-akebia-therapeutics
Earnings Preview For Akebia Therapeutics
08/06/2025 19:03:28

akebia-therapeutics-initiates-post-marketing-study-to-identify-additional-potential-benefits-of-vafseo
Akebia Therapeutics Initiates Post-Marketi...
08/04/2025 12:09:08

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION